Fundraising FoxGörlich Gruppe
Family officeBerlin · 3 people tracked
Find your way into Görlich Gruppe
Sign up to see every warm intro you have to Görlich Gruppe
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Görlich Gruppe team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Görlich Family Office operates with a multi-generational, disciplined yet risk-tolerant approach to wealth management, drawing on its experience with real estate holding companies to move into new sectors. It always co-invests with its clients, who are experienced in capital participations and able to bear risk. The firm sees biotechnology as a technology transforming medicine and acts as lead investor through its fund vehicle, giving semi-professional and professional investors access to this field. A current example is its lead investment via a special fund in 4TEEN4 Pharmaceuticals GmbH, developing a treatment for cardiogenic shock and an early-detection biomarker.
Source: firm website, verified Aug 3, 2026.
Team · 3 people
from the firm's website
Born 1979 in Bielefeld, he studied international business and holds an MBA; he ran the group's Brazilian operations from 2005 to 2018 before returning to lead the Berlin family office. He oversees the family's real estate holdings and founded GG Capital Management for biotech investments.
Born 1998 in Berlin, he studied economics and public policy and worked in management consulting before joining as co-managing director in 2024. He handles the family's capital market investments and advises portfolio company 4TEEN4 on finance and communications.
Born 1949, a lawyer with a background in corporate and tax law who founded and led the Dr. Görlich GmbH issuing house, becoming a leading figure in Germany's closed-end real estate fund market. Today he serves as an advisor to the succeeding generations.
What they invest in
from 1 of 2 portfolio companiesBiotech ×1Healthtech ×1Medical Devices ×1
HQs:Germany×1
Investments · 2 tracked
founders shown can be your intro path
4TEEN4 develops monoclonal antibody therapeutics targeting shock and critical illness in patients.
BiotechHealthtechMedical DevicesHennigsdorf, DE
Dr. Andreas Bergmann(CEO)Dr. Joachim Struck(CRO)Dr. Karine Bourgeois(CSO)Prof. Mahir Karakas(CMO)inDr. Kilian von Seldeneck(CFO)Dr. Chris Springer(COO)in
Co-investorsBrandenburg Kapital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
4TEEN4
Portfolio news
latest coverage across their companiesFrequently asked questions
- What sectors does Görlich Gruppe focus on?
- Görlich Gruppe focuses on Biotech, PropTech, Sector Agnostic.
- Where is Görlich Gruppe located?
- Görlich Gruppe is headquartered in Berlin, DE.
- Does Görlich Gruppe lead rounds?
- Yes, Görlich Gruppe leads investment rounds.
Similar investors
Blume Ventures is a seed and pre-Series A investment firm headquartered in Mumbai that focuses on early-stage companies in India.
Correlation Ventures is a venture capital firm that emphasizes a fast, data-driven investment process, using a large VC dataset and its network to support startups.
daphni is a venture capital firm that describes its approach as human-driven, community-powered and tech-augmented, backed by a community of over 400 members.
Founders Fund is a venture capital firm that backs technology companies building transformative products.
Index Ventures is a venture capital firm that backs founders across industries and geographies, emphasizing the people behind ideas as much as the businesses themselves.